What is the Emerging Priorities and Consumer-Driven Research initiative?

This initiative will:

  • improve patient care
  • translate new discoveries into clinical practice
  • encourage researchers to work together with the public on projects that matter to the public
  • connect researchers to consumers, carers and clinicians and foster partnerships

This initiative includes projects previously covered under the Accelerated Research initiative.

Why is the Emerging Priorities and Consumer-Driven Research initiative important?

This initiative aims to assist Australians to benefit from new treatments for conditions that are in emerging priority areas or areas of unmet need.

What are the goals of the Emerging Priorities and Consumer-Driven Research initiative?

The initiative’s goals are to support research that improves patient care and translation of new discoveries, and encourage collaboration between consumers and researchers.

How will we meet these goals?

We will run open and targeted grant opportunities with a focus on collaboration between consumers and researchers in addressing unmet need and emerging priorities.

See the initiative snapshot for details of how we plan to meet these goals.

MRFF snapshot – Emerging Priorities and Consumer-Driven Research

This snapshot shows this initiative at a glance. It includes budgets, early funding priorities and grant timelines, as at November 2019. Researchers and other stakeholders can use it to plan for upcoming opportunities and see how the initiative will be established, expanded and embedded over time.

Who works with us on the Emerging Priorities and Consumer-Driven Research initiative?

The Medical Research Future Fund (MRFF) funds this initiative.

Our Health and Medical Research Office oversees this and other MRFF initiatives.

The National Health and Medical Research Council (NHMRC) and the Department of Industry, Science, Energy and Resources administer this initiative. 

Apply for funding

We will list grants on GrantConnect when they open. If you want GrantConnect to notify you about future MRFF grants:

  • register with them
  • enter ‘MRFF’ in the keyword section of your GrantConnect profile

Status

Upcoming grants

    There are currently no upcoming grant opportunities.

    Open grant rounds

    The 2020 Childhood Cancer Research grant opportunity opened on 7 October 2020 and will close on 3 February 2021.

      Grants being assessed

       We are currently assessing applications recived under:

      • the 2020 Medicinal Cannabis Clinical Trials opportunity and
      • the 2020 Silicosis Research opportunity.

      Grants awarded

      We have awarded the following grants under this initiative, as at 30 October 2020.

      Funded Institution

      Project Name

      Chief Investigator/s

      Total Funding

      Monash University

      The PARC study: A phase I/II study evaluating the safety and activity of Pegylated recombinant human Arginase (BCT-100) Relapsed/refractory Cancers of Children and Young Adults

      Doctor Maria Kirby

      $480,015

      University of Melbourne

      Role of the NKp44-PDGF-DD axis in Glioblastoma

      Doctor Alexander Barrow

      $573,689

      University of Melbourne

      Targeting invadopodia to treat glioblastoma

      Doctor Stanley Stylli

      $384,526

      Cancer Council SA

      Support research into the cause and potential therapies for people with cancer

      Not applicable

      $3,000,000

      Murdoch Children's Research Institute

      A project to enable the Australian Genomics Health Alliance to extend the cardiovascular genetic disorders flagship study

      Not applicable

      $6,000,000

      The Jean Hailes Foundation

      To establish the National Endometriosis Clinical and Scientific Trials Network (NECST). The project will build a national research platform that supports a comprehensive national program of clinical, basic science and translational research relevant to the needs of Australian endometriosis sufferers

      Not applicable

      $2,500,000

      JDRF Australia

      The Foundation will accelerate translational research and develop innovative treatments, and also will build collaborative and diverse expertise across the Australian health sector, attract international research to Australia and increase participation of patients in clinical trials

      Not applicable

      $25,000,000

      Sanfilippo Children's Foundation (NSW)

      Personalised medicine approach for Australian children with Sanfilippo Syndrome (MPS III)

      Not applicable

      $2,000,000

      University of Melbourne

      Advancing stem cell research in clinical care for incurable medical conditions or conditions with unmet clinical need

      Not applicable

      $3,000,000

      Epilepsy Foundation (VIC)

      Funding for the Epilepsy Foundation to advance research into treatments including a proof-of-concept study to demonstrate how gene therapy can correct SYNGAP mutations to be conducted by the Florey Institute

      Not applicable

      $2,000,000

      Cerebral Palsy Alliance (NSW)

      Funding to drive research to support the treatment of Cerebral Palsy sponsored by the Cerebral Palsy Alliance. Includes a clinical trial to test the validity of the TheraSuit conducted by the Hudson Medical Research Institute

      Not applicable

      $2,000,000

      Murdoch Children's Research Institute

      The Leukodystrophy Flagship will increase research into the causes of the disease, build new disease models, build evidence for complementary genomic approaches, and develop a patients' bioregistry

      Not applicable

      $3,000,000

      Cure for MND Foundation

      The project will facilitate new clinical trial activity for drug repurposing in the treatment of Motor Neurone Disease (MND) and provide greater access to innovative and cutting edge approaches to treating MND

      Not applicable

      $1,960,000

      Cure for MND Foundation

      Expand clinical trials of repurposed drugs for the treatment of Motor Neurone Disease

      Not applicable

      $6,000,000

      St George and Sutherland Medical Research Foundation

      Studies on the role of the gut microbiome in health and disease

      Not applicable

      $2,000,000

      Murdoch University

      To establish the Australian National Phenome Centre

      Not applicable

      $10,000,000

      Olivia Newton-John Cancer Research Institute

      Rare Cancer trial - combination treatment with Ipilimumab and Nivolumab at rural sites

      Not applicable

      $1,000,000

      Maddie Riewoldt Holdings Limited

      Clinical trials capacity building for patients with Bone Marrow Failure Syndromes in Australia

      Not applicable

      $1,000,000

      The Walter and Eliza Hall Institute of Medical Research

      The establishment of a new national Drug Discovery Centre that will fast track the translation of scientific discoveries into new medicines and treatments

      Not applicable

      $25,000,000

      CanTeen

      Supporting new clinical trials for adolescents and young adults with cancer

      Not applicable

      $5,000,000

      The University of Queensland

      National expansion of the project 'Safer Baby Bundle' which is designed to reduce the rate of stillbirth after 28 weeks' gestation by at least 20%. The 'Safer Baby Bundle' will provide evidence-based information about steps to take to reduce the risk of stillbirth, and an educational program for midwives and doctors on best practice care after stillbirth

      Not applicable

      $3,000,000

      National Stroke Foundation

      Development of the Australian Living Guidelines for Stroke Management (in conjunction with Cochrane Australia) and targeted clinical research on stroke recovery for young survivors - 'Return to life, return to work'

      Not applicable

      $2,500,000

      The Garvan Institute of Medical Research/University of New South Wales

      Integrating genomics, biomarkers and patient cell phenotyping into disease modifying clinical trials to identify therapeutics to slow or stop Parkinson’s disease progression

      Not applicable

      $30,000,000

      Australian National University

      Develop Australia's phenomics capability by improving the translation of human genomics-to-phenomics, and by optimising new discoveries and innovations

      Not applicable

      $10,000,000

      The Movember Foundation

      Establishing three Prostate Cancer Research Alliances at the Peter MacCallum Cancer Centre in Melbourne, St Vincent's Hospital Sydney and the University of Melbourne. Research will support earlier identification and optimal treatment of men at high risk of disease progression

      Not applicable

      $6,000,000

      Griffith University

      Conduct clinical trials on a new malaria vaccine

      Not applicable

      $500,000

      Victoria University

      Changing Practice: Mental and Physical Health of Girls and Women

      Not applicable

      $1,000,000

      University of Tasmania

      Multiple Sclerosis Medical Research Flagship Program

      Not applicable

      $10,000,000

      Australian Genomic Cancer Medicine Centre Ltd

      ASPiRATION: assessing the impact of genomic profiling in lung cancer

      Not applicable

      $5,000,000

      Monash University

      Autism Spectrum Disorders and Comorbid Disorders: Diagnosis and Treatment

      Not applicable

      $2,500,000

      Maddie Riewoldt Holdings Limited

      The RESELECT Trial

      Not applicable

      $1,020,000

      Australian National University

      Building community resilience to promote mental health in bushfire-affected communities

      Professor Iain Walker

      $295,038

      Australian National University

      The short and long term impacts of bushfires on children and their caregivers mental health: Using the Longitudinal Study of Australian Children to understand the economic, family and community protective factors

      Associate Professor Benjamin Edwards

      $135,348

      University of Western Australia

      Supporting the ongoing wellbeing and resilience of Australia's first responders following the 2019/20 bushfires

      Associate Professor David Lawrence

      $642,196

      University of Canberra

      Supporting mental health through building resilience during and after bushfires: lessons from the 2019-20 bushfires in southern NSW and the ACT

      Associate Professor Jacki Schirmer

      $322,235

      The University of New England

      Enhancing social and emotional wellbeing healing through arts-based storytelling for Aboriginal communities of northern inland NSW bushfire affected areas

      Professor Kim Usher

      $624,023

      Monash University

      Physiological impacts of prolonged bushfire smoke exposure on first responders and outdoor workers

      Professor Malcolm Sim

      $556,143

      The University of Newcastle

      Bushfire Impact on Vulnerable Groups: the respiratory burden and effective community solutions

      Professor Peter Gibson

      $864,480

      University of New South Wales

      A randomised controlled trial of mask use in control of respiratory outcomes during bushfire season

      Professor Raina MacIntyre

      $473,135

      University of Technology Sydney

      Defining and treating the physiological effects of bushfire smoke exposure

      Professor Philip Hansbro

      $1,087,404

      Deakin University

      A Randomized Controlled Trial Comparing Yoga, Cognitive Behaviour Therapy and Education to Improve Quality of Life and Reduce Healthcare Costs in Endometriosis

      Doctor Subhadra Evans

      $893,981

      Monash University

      Creating an evidence base for clinical care: A randomized controlled study examining the efficacy of the low FODMAP diet for the relief of gastrointestinal symptoms in endometriosis

      Associate Professor Jane Muir

      $948,619

      Murdoch Children's Research Institute

      Long STEPPP-A Longitudinal Study of Teenagers with Endometriosis, Period and Pelvic Pain in Australia to identify early risk factors, educational and management strategies that will lead to optimal health outcomes and appropriate health utilisation

      Professor Sonia Grover

      $1,963,118

      University of Melbourne

      Improving diagnosis and treatment of endometriosis

      Professor Peter Rogers

      $3,929,234

      The University of Queensland

      Genetic variants, Early Life exposures, and Longitudinal Endometriosis Symptoms study (GELLES)

      Professor Gita Mishra

      $1,856,540

      University of New South Wales

      Men and infertility over the lifecourse

      Not applicable

      $4,600,000

      The Council of the Queensland Institute of Medical Research

      Australian Pharmacogenomics Diversity Project: Examining the evidence and improving the performance of pharmacogenomics in the Australian context

      Professor Sarah Medland

      $1,371,571

      University of Melbourne

      The PRESIDE (PhaRmacogEnomicS In Depression) Trial: an RCT of pharmacogenomically-informed prescribing of antidepressants on depression outcomes in patients with major depressive disorder in primary care

      Professor Jon Emery

      $1,390,401

      University of New South Wales

      A multifaceted approach to the pharmacogenomic signatures of bipolar disorder for improving treatment outcomes

      Associate Professor Janice Fullerton

      $1,009,768

      University of New South Wales

      An Australian Multicentre Double-Blinded Randomised Controlled Trial of Genotype-guided versus Standard Psychotropic Therapy in Moderately-to-Severely Depressed Patients Initiating Pharmacotherapy

      Doctor Kathy Wu

      $2,954,041

      Monash University

      National Women’s Health Research, Translation and Impact Network

      Not applicable

      $5,000,000

      Griffith University

      A Phase II trial evaluating feasibility, safety and efficacy of an individually-tailored exercise intervention during chemotherapy for recurrent ovarian cancer

      Professor Sandra Hayes

      $884,172

      Monash University

      Measuring adherence to best practice guidelines for the management of ovarian cancer in Australia to determine the extent to which variation in care influences clinical and patient-reported outcomes

      Professor John Zalcberg

      $3,520,935

      Monash University

      Towards A New Era in Granulosa Cell Tumour Research: Patient Driven Outcomes, Genomics, Diagnostics & Therapeutics

      Professor Peter Fuller

      $2,218,870

      The Council of the Queensland Institute of Medical Research

      Ovarian cancer: investigating Variation in care and survival, Aetiology and Risk factors to Improve outcomes in Australia via National data linkage. The OVARIAN study

      Professor Penelope Webb

      $2,707,035

      University of Melbourne

      High throughput discovery of synergistic drug combinations for patients with low-grade serous ovarian cancer

      Doctor Dane Cheasley

      $1,109,189

      The University of Newcastle

      Australian Program for Drug Repurposing for Treatment Resistant Ovarian Cancer Treatment

      Associate Professor Nikola Bowden

      $2,693,815

      The University of Queensland

      A new radio-imaging agent to guide targeted therapy for epithelial ovarian cancer

      Associate Professor Paul Thomas

      $1,893,306

      The University of Queensland

      Ovarian cancer early detection, monitoring and therapeutic intervention using extracellular vesicles

      Doctor Carlos Salomon

      $1,213,468

      University of New South Wales

      Zero Childhood Cancer

      Not applicable

      $54,800,000

      Total

      $275,376,295

      We publish the details of all MRFF grants we have approved after they have been tabled at budget estimates, supplementary budget estimates or additional estimates. This means there is a delay between us approving grants and the details appearing here.

      Related information

      See a list of all MRFF grant recipients.

      Contact

      For more information, contact us.

      Medical Research Future Fund (MRFF) contact

      Contact for more information about the Medical Research Future Fund (MRFF), or to provide feedback on the MRFF website.

      General enquiries:
      MRFF [at] health.gov.au
      MRFF website or newsletter feedback:
      HMRO [at] health.gov.au

      View contact

      Department of Industry, Science, Energy and Resources

      Contact the Department of Industry, Science, Energy and Resources from 8am to 8pm, Monday to Friday (excluding public holidays).

      Medical Research Future Fund inquiries
      MRFF [at] industry.gov.au

      View contact

      National Health and Medical Research Council (NHMRC)

      The National Health and Medical Research Council (NHMRC) funds high quality health and medical research to build research capability, support researchers, encourage the translation of research into better health outcomes and promote the highest ethical standards for health and medical research.

      help [at] nhmrc.gov.au

      View contact

      Last updated: 
      16 November 2020